Roche taps Manifold Bio to cross the brain barrier
FierceBiotech - 03-Nov-2025$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Join the club for FREE to access the whole archive and other member benefits.
$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation
Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
Startup aims to add 20 healthy years through advanced epigenetic age testing
Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug
Wegovy maker faces leadership overhaul after dispute with its largest shareholder
NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies
PP405 shows early promise in reactivating dormant hair follicles to restore growth
Their goal is to make treatments faster, safer, and more effective
Easing regulations and new drug approvals fuel optimism for a sustained biotech rally
Trials showed fewer hospital visits and faster access to care
Interim trials show improved weight, muscle, and vitality in aging cats with TCHC therapies
Partnership aims to uncover disease-driving genes and boost precision drug development
Cirrus Therapeutics targets aging biology to combat blindness from dry AMD
Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials
Oura doubles valuation to $10.9B after selling 5.5M rings and projecting $1B+ revenue in 2025
First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
Backed by J&J, Carina robot gains traction in China with global approvals on the horizon
Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients
Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
New funding terms cut early stakes by up to 100-to-1, threatening trust in longevity biotech
Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Startup uses AI to explore billions of molecules for next-gen skincare innovation
New DeSci platform uses tokens and AI to speed breakthroughs in ageing research